LYVE1 Antikörper (AA 20-238)

Produktnummer ABIN7158607

Produktdetails anti-LYVE1 Antikörper

Target: LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))

Bindungsspezifität: AA 20-238

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LYVE1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Kreuzreaktivität: Human, Maus

Aufreinigung: Antigen Affinity Purified

Immunogen: Recombinant Human Lymphatic vessel endothelial hyaluronic acid receptor 1 protein (20-238AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu LYVE1

Target: LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))

Andere Bezeichnung: LYVE1 (LYVE1 Produkte)

Synonyme: LYVE1 antikoerper, XLKD1 antikoerper, CRSBP-1 antikoerper, HAR antikoerper, LYVE-1 antikoerper, 1200012G08Rik antikoerper, Crsbp-1 antikoerper, Lyve-1 antikoerper, Xlkd1 antikoerper, lymphatic vessel endothelial hyaluronic receptor 1a antikoerper, lymphatic vessel endothelial hyaluronan receptor 1 antikoerper, lyve1a antikoerper, LYVE1 antikoerper, Lyve1 antikoerper

Hintergrund:

Background: Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as a hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes.

Aliases: Cell surface retention sequence-binding protein 1 antibody, CRSBP 1 antibody, CRSBP-1 antibody, CRSBP1 antibody, extracellular link domain containing 1 antibody, extracellular link domain-containing 1 antibody, Extracellular link domain-containing protein 1 antibody, HAR antibody, Hyaluronic acid receptor antibody, Lymphatic endothelium specific hyaluronan receptor antibody, lymphatic vessel endothelial hyaluronan receptor 1 antibody, Lymphatic vessel endothelial hyaluronic acid receptor 1 antibody, LYVE 1 antibody, LYVE-1 antibody, LYVE1 antibody, LYVE1_HUMAN antibody, XLKD1 antibody

UniProt: Q9Y5Y7

Pathways: Glycosaminoglycan Metabolic Process